Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

University: Texas Medical Center

You searched for subject:(lung cancer). Showing records 1 – 22 of 22 total matches.

Search Limiters

Last 2 Years | English Only

▼ Search Limiters


Texas Medical Center

1. Chen, Yulong. LOSS OF GPRC5A ENHANCES SURVIVAL IN NORMAL AND MALIGNANT LUNG EPITHELIAL CELLS BY ELICITING PERSISTENT STAT3 ACTIVATION INDUCED BY AUTOCRINE LIF.

Degree: PhD, 2010, Texas Medical Center

  Signal transduction and activator of transcription 3 (Stat3) is activated by cytokines and growth factors in many cancers. Persistent activation of Stat3 plays important… (more)

Subjects/Keywords: lung cancer; Gprc5a; tumor suppressor; Stat3; Lif; survival; Cancer Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, Y. (2010). LOSS OF GPRC5A ENHANCES SURVIVAL IN NORMAL AND MALIGNANT LUNG EPITHELIAL CELLS BY ELICITING PERSISTENT STAT3 ACTIVATION INDUCED BY AUTOCRINE LIF. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/61

Chicago Manual of Style (16th Edition):

Chen, Yulong. “LOSS OF GPRC5A ENHANCES SURVIVAL IN NORMAL AND MALIGNANT LUNG EPITHELIAL CELLS BY ELICITING PERSISTENT STAT3 ACTIVATION INDUCED BY AUTOCRINE LIF.” 2010. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/61.

MLA Handbook (7th Edition):

Chen, Yulong. “LOSS OF GPRC5A ENHANCES SURVIVAL IN NORMAL AND MALIGNANT LUNG EPITHELIAL CELLS BY ELICITING PERSISTENT STAT3 ACTIVATION INDUCED BY AUTOCRINE LIF.” 2010. Web. 17 Jul 2018.

Vancouver:

Chen Y. LOSS OF GPRC5A ENHANCES SURVIVAL IN NORMAL AND MALIGNANT LUNG EPITHELIAL CELLS BY ELICITING PERSISTENT STAT3 ACTIVATION INDUCED BY AUTOCRINE LIF. [Internet] [Doctoral dissertation]. Texas Medical Center; 2010. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/61.

Council of Science Editors:

Chen Y. LOSS OF GPRC5A ENHANCES SURVIVAL IN NORMAL AND MALIGNANT LUNG EPITHELIAL CELLS BY ELICITING PERSISTENT STAT3 ACTIVATION INDUCED BY AUTOCRINE LIF. [Doctoral Dissertation]. Texas Medical Center; 2010. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/61


Texas Medical Center

2. Pierzynski, Jeanne; and#60;pand#62;and#60;a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__orcid.org_0000-2D0001-2D6647-2D2025andd=CwMCAAandc=6vgNTiRn9_pqCD9hKx9JgXN1VapJQ8JVoF8oWH1AgfQandr=z8uU2nw7a_sHiW_O3PzfxomF2BxqZY7_EQFipBSj4WIandm=_hCWL_3QtPgydCjN5Lhb-0deeh_3Ala2dVgcdTMSEl4ands=AvR1NLjoxNHOwU8MbURVRK7v08chcSHAHkAMpZgSv2cande=" target="_blank"and#62;0000-0001-6647-2025and#60;/aand#62;and#60;/pand#62. Quality of Life: Socio-Demographic and Genetic Determinants as well as Links with Cancer Outcomes.

Degree: PhD, 2017, Texas Medical Center

  Quality of life (QOL) is an independent prognostic factor for cancer. Lung cancer is the leading cause of cancer death. Breast cancer is the… (more)

Subjects/Keywords: Quality of Life; Lung Cancer; Breast Cancer; Bladder Cancer; Single Nucleotide Polymorphisms; Cancer Clinical Outcomes; Epidemiology; Genetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pierzynski, J. a. h. p. c. o. t. (2017). Quality of Life: Socio-Demographic and Genetic Determinants as well as Links with Cancer Outcomes. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/819

Chicago Manual of Style (16th Edition):

Pierzynski, Jeanne; and#60;pand#62;and#60;a href="https://urldefense proofpoint com/v2/url?u=http-3A__orcid org_0000-2D0001-2D6647-2D2025andd=CwMCAAandc=6vgNTiRn9_pqCD9hKx9JgXN1VapJQ8JVoF8oWH1AgfQandr=z8uU2nw7a_sHiW_O3PzfxomF2BxqZY7_EQFipBSj4WIandm=_hCWL_3QtPgydCjN5Lhb-0deeh_3Ala2dVgcdTMSEl4ands=AvR1NLjoxNHOwU8MbURVRK7v08chcSHAHkAMpZgSv2cande=" target="_blank"and#62;0000-0001-6647-2025and#60;/aand#62;and#60;/pand#62. “Quality of Life: Socio-Demographic and Genetic Determinants as well as Links with Cancer Outcomes.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/819.

MLA Handbook (7th Edition):

Pierzynski, Jeanne; and#60;pand#62;and#60;a href="https://urldefense proofpoint com/v2/url?u=http-3A__orcid org_0000-2D0001-2D6647-2D2025andd=CwMCAAandc=6vgNTiRn9_pqCD9hKx9JgXN1VapJQ8JVoF8oWH1AgfQandr=z8uU2nw7a_sHiW_O3PzfxomF2BxqZY7_EQFipBSj4WIandm=_hCWL_3QtPgydCjN5Lhb-0deeh_3Ala2dVgcdTMSEl4ands=AvR1NLjoxNHOwU8MbURVRK7v08chcSHAHkAMpZgSv2cande=" target="_blank"and#62;0000-0001-6647-2025and#60;/aand#62;and#60;/pand#62. “Quality of Life: Socio-Demographic and Genetic Determinants as well as Links with Cancer Outcomes.” 2017. Web. 17 Jul 2018.

Vancouver:

Pierzynski Jahpcot. Quality of Life: Socio-Demographic and Genetic Determinants as well as Links with Cancer Outcomes. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/819.

Council of Science Editors:

Pierzynski Jahpcot. Quality of Life: Socio-Demographic and Genetic Determinants as well as Links with Cancer Outcomes. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/819


Texas Medical Center

3. Ungewiss, Christin. MICRORNA-200 REGULATES ECM-DEPENDENT β1-INTEGRIN/FAK SIGNALING AND CANCER CELL INVASION.

Degree: PhD, 2015, Texas Medical Center

  The microRNA-200 family is known to be a master regulator of the epithelial-to-mesenchymal transition, partially through its double-negative feedback loop with the transcriptional repressor… (more)

Subjects/Keywords: miR-200; lung cancer; metastases; EMT; Integrin b1; FAK; CRKL; Cancer Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ungewiss, C. (2015). MICRORNA-200 REGULATES ECM-DEPENDENT β1-INTEGRIN/FAK SIGNALING AND CANCER CELL INVASION. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/561

Chicago Manual of Style (16th Edition):

Ungewiss, Christin. “MICRORNA-200 REGULATES ECM-DEPENDENT β1-INTEGRIN/FAK SIGNALING AND CANCER CELL INVASION.” 2015. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/561.

MLA Handbook (7th Edition):

Ungewiss, Christin. “MICRORNA-200 REGULATES ECM-DEPENDENT β1-INTEGRIN/FAK SIGNALING AND CANCER CELL INVASION.” 2015. Web. 17 Jul 2018.

Vancouver:

Ungewiss C. MICRORNA-200 REGULATES ECM-DEPENDENT β1-INTEGRIN/FAK SIGNALING AND CANCER CELL INVASION. [Internet] [Doctoral dissertation]. Texas Medical Center; 2015. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/561.

Council of Science Editors:

Ungewiss C. MICRORNA-200 REGULATES ECM-DEPENDENT β1-INTEGRIN/FAK SIGNALING AND CANCER CELL INVASION. [Doctoral Dissertation]. Texas Medical Center; 2015. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/561


Texas Medical Center

4. Zhang, Fanmao. Novel serum biomarkers for lung cancer early diagnosis and clinical outcome.

Degree: PhD, 2014, Texas Medical Center

  The five-year survival rate for all stages of lung cancer combined is only 17%, which has changed little over the past 40 years. Despite… (more)

Subjects/Keywords: Lung cancer; serum biomarker; metabolism; Epidemiology; Medicine and Health Sciences; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, F. (2014). Novel serum biomarkers for lung cancer early diagnosis and clinical outcome. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/477

Chicago Manual of Style (16th Edition):

Zhang, Fanmao. “Novel serum biomarkers for lung cancer early diagnosis and clinical outcome.” 2014. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/477.

MLA Handbook (7th Edition):

Zhang, Fanmao. “Novel serum biomarkers for lung cancer early diagnosis and clinical outcome.” 2014. Web. 17 Jul 2018.

Vancouver:

Zhang F. Novel serum biomarkers for lung cancer early diagnosis and clinical outcome. [Internet] [Doctoral dissertation]. Texas Medical Center; 2014. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/477.

Council of Science Editors:

Zhang F. Novel serum biomarkers for lung cancer early diagnosis and clinical outcome. [Doctoral Dissertation]. Texas Medical Center; 2014. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/477


Texas Medical Center

5. Pu, Xia. Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients.

Degree: PhD, 2012, Texas Medical Center

Lung cancer is the leading cause of cancer-related mortality in the US. Emerging evidence has shown that host genetic factors can interact with environmental… (more)

Subjects/Keywords: Lung Cancer; clinical outcomes; polymorphism; Epidemiology; Medicine and Health Sciences; Public Health

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pu, X. (2012). Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/264

Chicago Manual of Style (16th Edition):

Pu, Xia. “Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients.” 2012. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/264.

MLA Handbook (7th Edition):

Pu, Xia. “Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients.” 2012. Web. 17 Jul 2018.

Vancouver:

Pu X. Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients. [Internet] [Doctoral dissertation]. Texas Medical Center; 2012. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/264.

Council of Science Editors:

Pu X. Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients. [Doctoral Dissertation]. Texas Medical Center; 2012. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/264


Texas Medical Center

6. Roybal, Jonathon D. The Role of Cancer-Associated Fibroblasts in Lung Tumorigenesis.

Degree: PhD, 2011, Texas Medical Center

  The extracellular milieu is rich in growth factors that drive tumor progression,but the mechanisms that govern tumor cell sensitivity to those ligands have notbeen… (more)

Subjects/Keywords: Stroma; Lung; miRNA; miR-200; Cancer-Associated Fibroblasts; Tumorigenesis; VEGF-A; VEGFR1; Cancer Biology; Cell Biology; Molecular Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roybal, J. D. (2011). The Role of Cancer-Associated Fibroblasts in Lung Tumorigenesis. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/135

Chicago Manual of Style (16th Edition):

Roybal, Jonathon D. “The Role of Cancer-Associated Fibroblasts in Lung Tumorigenesis.” 2011. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/135.

MLA Handbook (7th Edition):

Roybal, Jonathon D. “The Role of Cancer-Associated Fibroblasts in Lung Tumorigenesis.” 2011. Web. 17 Jul 2018.

Vancouver:

Roybal JD. The Role of Cancer-Associated Fibroblasts in Lung Tumorigenesis. [Internet] [Doctoral dissertation]. Texas Medical Center; 2011. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/135.

Council of Science Editors:

Roybal JD. The Role of Cancer-Associated Fibroblasts in Lung Tumorigenesis. [Doctoral Dissertation]. Texas Medical Center; 2011. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/135


Texas Medical Center

7. Baird, Brandi N. Fibulin-2 stabilizes tumor extracellular matrix and drives malignant progression of lung adenocarcinoma.

Degree: PhD, 2012, Texas Medical Center

  The ECM of epithelial carcinomas undergoes structural remodeling during periods of uncontrolled growth, creating regional heterogeneity and torsional stress. How tumors maintain ECM integrity… (more)

Subjects/Keywords: Fibulin-2; extracellular matrix; lung cancer; metastasis; cancer-associated fibroblasts; collagen; Medicine and Health Sciences; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baird, B. N. (2012). Fibulin-2 stabilizes tumor extracellular matrix and drives malignant progression of lung adenocarcinoma. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/297

Chicago Manual of Style (16th Edition):

Baird, Brandi N. “Fibulin-2 stabilizes tumor extracellular matrix and drives malignant progression of lung adenocarcinoma.” 2012. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/297.

MLA Handbook (7th Edition):

Baird, Brandi N. “Fibulin-2 stabilizes tumor extracellular matrix and drives malignant progression of lung adenocarcinoma.” 2012. Web. 17 Jul 2018.

Vancouver:

Baird BN. Fibulin-2 stabilizes tumor extracellular matrix and drives malignant progression of lung adenocarcinoma. [Internet] [Doctoral dissertation]. Texas Medical Center; 2012. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/297.

Council of Science Editors:

Baird BN. Fibulin-2 stabilizes tumor extracellular matrix and drives malignant progression of lung adenocarcinoma. [Doctoral Dissertation]. Texas Medical Center; 2012. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/297


Texas Medical Center

8. Ruder, Dennis. CONCOMITANT TARGETING OF THE MTOR/MAPK PATHWAYS: NOVEL THERAPEUTIC STRATEGY IN SUBSETS OF NON-SMALL CELL LUNG CANCER.

Degree: PhD, 2016, Texas Medical Center

  Over the last decade, a paradigm-shift in lung cancer therapy has evolved into targeted-driven medicinal approaches. However, patients frequently relapse and develop resistance to… (more)

Subjects/Keywords: RICTOR; KRAS; Non-small cell lung cancer; mTOR; MAPK; Cancer Biology; Genetics; Genomics; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ruder, D. (2016). CONCOMITANT TARGETING OF THE MTOR/MAPK PATHWAYS: NOVEL THERAPEUTIC STRATEGY IN SUBSETS OF NON-SMALL CELL LUNG CANCER. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/725

Chicago Manual of Style (16th Edition):

Ruder, Dennis. “CONCOMITANT TARGETING OF THE MTOR/MAPK PATHWAYS: NOVEL THERAPEUTIC STRATEGY IN SUBSETS OF NON-SMALL CELL LUNG CANCER.” 2016. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/725.

MLA Handbook (7th Edition):

Ruder, Dennis. “CONCOMITANT TARGETING OF THE MTOR/MAPK PATHWAYS: NOVEL THERAPEUTIC STRATEGY IN SUBSETS OF NON-SMALL CELL LUNG CANCER.” 2016. Web. 17 Jul 2018.

Vancouver:

Ruder D. CONCOMITANT TARGETING OF THE MTOR/MAPK PATHWAYS: NOVEL THERAPEUTIC STRATEGY IN SUBSETS OF NON-SMALL CELL LUNG CANCER. [Internet] [Doctoral dissertation]. Texas Medical Center; 2016. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/725.

Council of Science Editors:

Ruder D. CONCOMITANT TARGETING OF THE MTOR/MAPK PATHWAYS: NOVEL THERAPEUTIC STRATEGY IN SUBSETS OF NON-SMALL CELL LUNG CANCER. [Doctoral Dissertation]. Texas Medical Center; 2016. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/725


Texas Medical Center

9. Sutton, Margie Nicole; and#60;pand#62;0000-0002-9263-9877and#60;/pand#62. The Role of the DIRAS Family Members in Regulating Ras Function, Cancer Growth and Autophagy.

Degree: PhD, 2017, Texas Medical Center

  DIRAS3 is a maternally imprinted tumor suppressor gene that is downregulated by multiple mechanisms across several tumor types. When re-expressed, DIRAS3 decreases proliferation, inhibits… (more)

Subjects/Keywords: Ras; Autophagy; DIRAS; Ovarian Cancer; Pancreatic Cancer; Lung Cancer; GTPase; Biology; Cancer Biology; Cell Biology; Laboratory and Basic Science Research; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sutton, M. N. a. (2017). The Role of the DIRAS Family Members in Regulating Ras Function, Cancer Growth and Autophagy. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/741

Chicago Manual of Style (16th Edition):

Sutton, Margie Nicole; and#60;pand#62;0000-0002-9263-9877and#60;/pand#62. “The Role of the DIRAS Family Members in Regulating Ras Function, Cancer Growth and Autophagy.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/741.

MLA Handbook (7th Edition):

Sutton, Margie Nicole; and#60;pand#62;0000-0002-9263-9877and#60;/pand#62. “The Role of the DIRAS Family Members in Regulating Ras Function, Cancer Growth and Autophagy.” 2017. Web. 17 Jul 2018.

Vancouver:

Sutton MNa. The Role of the DIRAS Family Members in Regulating Ras Function, Cancer Growth and Autophagy. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/741.

Council of Science Editors:

Sutton MNa. The Role of the DIRAS Family Members in Regulating Ras Function, Cancer Growth and Autophagy. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/741


Texas Medical Center

10. Blatnica, Anthony. MODIFICATION AND IMPLEMENTATION OF THE RPC HETEROGENEOUS THORAX PHANTOM FOR VERIFICATION OF PROTON THERAPY TREATMENT PROCEDURES.

Degree: MS, 2011, Texas Medical Center

  The Radiological Physics Center (RPC) provides heterogeneous phantoms that are used to evaluate radiation treatment procedures as part of a comprehensive quality assurance program… (more)

Subjects/Keywords: Proton Therapy; Radiological Physics Center; heterogeneous thorax phantom; lung cancer; phantom; lung tissue equivalent material; balsa; linear energy transfer; EBT2 film; Other Physics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Blatnica, A. (2011). MODIFICATION AND IMPLEMENTATION OF THE RPC HETEROGENEOUS THORAX PHANTOM FOR VERIFICATION OF PROTON THERAPY TREATMENT PROCEDURES. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/110

Chicago Manual of Style (16th Edition):

Blatnica, Anthony. “MODIFICATION AND IMPLEMENTATION OF THE RPC HETEROGENEOUS THORAX PHANTOM FOR VERIFICATION OF PROTON THERAPY TREATMENT PROCEDURES.” 2011. Masters Thesis, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/110.

MLA Handbook (7th Edition):

Blatnica, Anthony. “MODIFICATION AND IMPLEMENTATION OF THE RPC HETEROGENEOUS THORAX PHANTOM FOR VERIFICATION OF PROTON THERAPY TREATMENT PROCEDURES.” 2011. Web. 17 Jul 2018.

Vancouver:

Blatnica A. MODIFICATION AND IMPLEMENTATION OF THE RPC HETEROGENEOUS THORAX PHANTOM FOR VERIFICATION OF PROTON THERAPY TREATMENT PROCEDURES. [Internet] [Masters thesis]. Texas Medical Center; 2011. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/110.

Council of Science Editors:

Blatnica A. MODIFICATION AND IMPLEMENTATION OF THE RPC HETEROGENEOUS THORAX PHANTOM FOR VERIFICATION OF PROTON THERAPY TREATMENT PROCEDURES. [Masters Thesis]. Texas Medical Center; 2011. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/110


Texas Medical Center

11. D'Amelio, Anthony M, Jr. Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease.

Degree: PhD, 2011, Texas Medical Center

  In 2011, there will be an estimated 1,596,670 new cancer cases and 571,950 cancer-related deaths in the US. With the ever-increasing applications of cancer(more)

Subjects/Keywords: Bayesian; Haplotypes; Single Nucleotide Polymorphisms; Risk Modeling; Hodgkin; Lung Cancer; Glioma; HapMap; Biostatistics; Statistical Models; Statistical Theory

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

D'Amelio, Anthony M, J. (2011). Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/197

Chicago Manual of Style (16th Edition):

D'Amelio, Anthony M, Jr. “Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease.” 2011. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/197.

MLA Handbook (7th Edition):

D'Amelio, Anthony M, Jr. “Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease.” 2011. Web. 17 Jul 2018.

Vancouver:

D'Amelio, Anthony M J. Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease. [Internet] [Doctoral dissertation]. Texas Medical Center; 2011. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/197.

Council of Science Editors:

D'Amelio, Anthony M J. Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease. [Doctoral Dissertation]. Texas Medical Center; 2011. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/197


Texas Medical Center

12. Fried, David. INVESTIGATION OF QUATITATIVE IMAGE FEATURES FROM PRETREATMENT CT AND FDG-PET SCANS IN STAGE III NSCLC PATIENTS UNDERGOING DEFINTIVE RADIATION THERAPY.

Degree: PhD, 2015, Texas Medical Center

  The purpose of this work was to determine if quantitative image features (QIFs) extracted from computed tomography (CT) and flourodeoxyglucose (FDG) positron emission tomography… (more)

Subjects/Keywords: Non-small cell lung cancer; quantitative image features; prognostic value; outcomes; modeling; texture; Medical Biophysics; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fried, D. (2015). INVESTIGATION OF QUATITATIVE IMAGE FEATURES FROM PRETREATMENT CT AND FDG-PET SCANS IN STAGE III NSCLC PATIENTS UNDERGOING DEFINTIVE RADIATION THERAPY. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/641

Chicago Manual of Style (16th Edition):

Fried, David. “INVESTIGATION OF QUATITATIVE IMAGE FEATURES FROM PRETREATMENT CT AND FDG-PET SCANS IN STAGE III NSCLC PATIENTS UNDERGOING DEFINTIVE RADIATION THERAPY.” 2015. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/641.

MLA Handbook (7th Edition):

Fried, David. “INVESTIGATION OF QUATITATIVE IMAGE FEATURES FROM PRETREATMENT CT AND FDG-PET SCANS IN STAGE III NSCLC PATIENTS UNDERGOING DEFINTIVE RADIATION THERAPY.” 2015. Web. 17 Jul 2018.

Vancouver:

Fried D. INVESTIGATION OF QUATITATIVE IMAGE FEATURES FROM PRETREATMENT CT AND FDG-PET SCANS IN STAGE III NSCLC PATIENTS UNDERGOING DEFINTIVE RADIATION THERAPY. [Internet] [Doctoral dissertation]. Texas Medical Center; 2015. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/641.

Council of Science Editors:

Fried D. INVESTIGATION OF QUATITATIVE IMAGE FEATURES FROM PRETREATMENT CT AND FDG-PET SCANS IN STAGE III NSCLC PATIENTS UNDERGOING DEFINTIVE RADIATION THERAPY. [Doctoral Dissertation]. Texas Medical Center; 2015. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/641


Texas Medical Center

13. ge, shuaiping; and#60;pand#62;0000-0003-3422-1445and#60;/pand#62. Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy Plans for Lung Cancer Patients with 4-Dimensional Robust Optimization.

Degree: PhD, 2017, Texas Medical Center

  A major challenge in the application of intensity-modulated proton therapy (IMPT) for lung cancer patients is the mitigation and consideration of uncertainties associated with… (more)

Subjects/Keywords: intensity modulated proton therapy; 4-dimensional robust optimization; motion management; uncertainties; lung cancer; Medicine and Health Sciences; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

ge, s. a. (2017). Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy Plans for Lung Cancer Patients with 4-Dimensional Robust Optimization. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/762

Chicago Manual of Style (16th Edition):

ge, shuaiping; and#60;pand#62;0000-0003-3422-1445and#60;/pand#62. “Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy Plans for Lung Cancer Patients with 4-Dimensional Robust Optimization.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/762.

MLA Handbook (7th Edition):

ge, shuaiping; and#60;pand#62;0000-0003-3422-1445and#60;/pand#62. “Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy Plans for Lung Cancer Patients with 4-Dimensional Robust Optimization.” 2017. Web. 17 Jul 2018.

Vancouver:

ge sa. Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy Plans for Lung Cancer Patients with 4-Dimensional Robust Optimization. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/762.

Council of Science Editors:

ge sa. Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy Plans for Lung Cancer Patients with 4-Dimensional Robust Optimization. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/762


Texas Medical Center

14. Fave, Xenia J; and#60;pand#62;orcid.org/0000-0003-0150-0843and#60;/pand#62. Detecting and Evaluating Therapy Induced Changes in Radiomics Features Measured from Non-Small Cell Lung Cancer to Predict Patient Outcomes.

Degree: PhD, 2017, Texas Medical Center

  The purpose of this study was to investigate whether radiomics features measured from weekly 4-dimensional computed tomography (4DCT) images of non-small cell lung cancers… (more)

Subjects/Keywords: Radiomics; Non-Small Cell Lung Cancer; Quantitative Imaging; Texture; Outcomes; Modeling; Medical Biomathematics and Biometrics; Multivariate Analysis; Other Physics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fave, X. J. a. o. (2017). Detecting and Evaluating Therapy Induced Changes in Radiomics Features Measured from Non-Small Cell Lung Cancer to Predict Patient Outcomes. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/778

Chicago Manual of Style (16th Edition):

Fave, Xenia J; and#60;pand#62;orcid org/0000-0003-0150-0843and#60;/pand#62. “Detecting and Evaluating Therapy Induced Changes in Radiomics Features Measured from Non-Small Cell Lung Cancer to Predict Patient Outcomes.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/778.

MLA Handbook (7th Edition):

Fave, Xenia J; and#60;pand#62;orcid org/0000-0003-0150-0843and#60;/pand#62. “Detecting and Evaluating Therapy Induced Changes in Radiomics Features Measured from Non-Small Cell Lung Cancer to Predict Patient Outcomes.” 2017. Web. 17 Jul 2018.

Vancouver:

Fave XJao. Detecting and Evaluating Therapy Induced Changes in Radiomics Features Measured from Non-Small Cell Lung Cancer to Predict Patient Outcomes. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/778.

Council of Science Editors:

Fave XJao. Detecting and Evaluating Therapy Induced Changes in Radiomics Features Measured from Non-Small Cell Lung Cancer to Predict Patient Outcomes. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/778


Texas Medical Center

15. Peng, David H; and#60;pand#62;0000-0003-0511-1888and#60;/pand#62. THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION.

Degree: PhD, 2017, Texas Medical Center

Lung cancer is the leading cause of cancer-related deaths due to conventional therapy resistance and metastatic disease, therefore understanding the mechanisms governing these biological… (more)

Subjects/Keywords: Lung cancer; EMT; drug resistance; metastasis; LOXL2; ECM; collagen; MAPK; Mek inhibitor; Cancer Biology; Laboratory and Basic Science Research; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Peng, D. H. a. (2017). THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/784

Chicago Manual of Style (16th Edition):

Peng, David H; and#60;pand#62;0000-0003-0511-1888and#60;/pand#62. “THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/784.

MLA Handbook (7th Edition):

Peng, David H; and#60;pand#62;0000-0003-0511-1888and#60;/pand#62. “THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION.” 2017. Web. 17 Jul 2018.

Vancouver:

Peng DHa. THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/784.

Council of Science Editors:

Peng DHa. THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/784


Texas Medical Center

16. Pan, Deng. THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION.

Degree: PhD, 2016, Texas Medical Center

  The transcription factor NF-κB plays a central role in many aspects of biological processes and diseases, such as inflammation and cancer. Although it has… (more)

Subjects/Keywords: NF-kB; MALT1; CARMA3; Lung Cancer; Breast Cancer; DNA damage; Signal Transduction; Animal Diseases; Animals; Biochemistry; Cancer Biology; Cell Biology; Disease Modeling; Medicine and Health Sciences; Molecular Biology; Molecular Genetics; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pan, D. (2016). THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/651

Chicago Manual of Style (16th Edition):

Pan, Deng. “THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION.” 2016. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/651.

MLA Handbook (7th Edition):

Pan, Deng. “THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION.” 2016. Web. 17 Jul 2018.

Vancouver:

Pan D. THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION. [Internet] [Doctoral dissertation]. Texas Medical Center; 2016. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/651.

Council of Science Editors:

Pan D. THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION. [Doctoral Dissertation]. Texas Medical Center; 2016. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/651


Texas Medical Center

17. Riegel, Adam C. Thoracic radiotherapy treatment planning with cine PET/CT.

Degree: PhD, 2010, Texas Medical Center

 Purpose: Respiratory motion causes substantial uncertainty in radiotherapy treatment planning. Four-dimensional computed tomography (4D-CT) is a useful tool to image tumor motion during normal respiration.… (more)

Subjects/Keywords: lung cancer; 4D-CT; PET/CT; radiation therapy; treatment planning; tumor delineation; dose calculation; cine CT; Medical Biophysics; Oncology; Other Physics; Radiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Riegel, A. C. (2010). Thoracic radiotherapy treatment planning with cine PET/CT. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/19

Chicago Manual of Style (16th Edition):

Riegel, Adam C. “Thoracic radiotherapy treatment planning with cine PET/CT.” 2010. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/19.

MLA Handbook (7th Edition):

Riegel, Adam C. “Thoracic radiotherapy treatment planning with cine PET/CT.” 2010. Web. 17 Jul 2018.

Vancouver:

Riegel AC. Thoracic radiotherapy treatment planning with cine PET/CT. [Internet] [Doctoral dissertation]. Texas Medical Center; 2010. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/19.

Council of Science Editors:

Riegel AC. Thoracic radiotherapy treatment planning with cine PET/CT. [Doctoral Dissertation]. Texas Medical Center; 2010. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/19


Texas Medical Center

18. Niedzielski, Joshua S. INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS.

Degree: PhD, 2016, Texas Medical Center

  Radiation injury in the esophagus occurs with high frequency from the treatment of non-small cell lung cancer (NSCLC). Radiation esophagitis is an acute normal… (more)

Subjects/Keywords: Radiation therapy; normal tissue toxicity; esophagitis; non small cell lung cancer; NTCP modelling; imaging biomarker; machine learning; functional imaging; 4DCT; FDG-PET; Other Medical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Niedzielski, J. S. (2016). INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/713

Chicago Manual of Style (16th Edition):

Niedzielski, Joshua S. “INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS.” 2016. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/713.

MLA Handbook (7th Edition):

Niedzielski, Joshua S. “INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS.” 2016. Web. 17 Jul 2018.

Vancouver:

Niedzielski JS. INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS. [Internet] [Doctoral dissertation]. Texas Medical Center; 2016. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/713.

Council of Science Editors:

Niedzielski JS. INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS. [Doctoral Dissertation]. Texas Medical Center; 2016. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/713

19. Massarelli, Erminia. CXCR2 EXPRESSION IN TUMOR CELLS IS A POOR PROGNOSTIC FACTOR AND PROMOTES INVASION AND METASTASIS IN LUNG ADENOCARCINOMA.

Degree: MS, 2013, Texas Medical Center

  CXC chemokine receptor 2 (CXCR2) is a G-protein coupled receptor which mediates signaling by binding to CXC chemokines CXCL1-3 and 5-8. In non-small cell… (more)

Subjects/Keywords: Lung adenocarcinoma; CXCR2; CXCL5; NSCLC; lung cancer metastases; CXCR2 ligands; Medical Cell Biology; Medicine and Health Sciences; Oncology

…and IL8 in non-small cell lung cancer cell lines and lung adenocarcinomas… …activated protein NKX2-1=thyroid transcription factor 1 NSCLC=non small cell lung cancer PC1… …growth factor VIM=vimentin x INTRODUCTION Lung cancer is responsible for over a million of… …Lung cancer histology drives the therapeutic decisions and chemotherapy choice. Small-cell… …material is reprinted by permission from the American Association for Cancer Research. Human lung… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Massarelli, E. (2013). CXCR2 EXPRESSION IN TUMOR CELLS IS A POOR PROGNOSTIC FACTOR AND PROMOTES INVASION AND METASTASIS IN LUNG ADENOCARCINOMA. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/409

Chicago Manual of Style (16th Edition):

Massarelli, Erminia. “CXCR2 EXPRESSION IN TUMOR CELLS IS A POOR PROGNOSTIC FACTOR AND PROMOTES INVASION AND METASTASIS IN LUNG ADENOCARCINOMA.” 2013. Masters Thesis, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/409.

MLA Handbook (7th Edition):

Massarelli, Erminia. “CXCR2 EXPRESSION IN TUMOR CELLS IS A POOR PROGNOSTIC FACTOR AND PROMOTES INVASION AND METASTASIS IN LUNG ADENOCARCINOMA.” 2013. Web. 17 Jul 2018.

Vancouver:

Massarelli E. CXCR2 EXPRESSION IN TUMOR CELLS IS A POOR PROGNOSTIC FACTOR AND PROMOTES INVASION AND METASTASIS IN LUNG ADENOCARCINOMA. [Internet] [Masters thesis]. Texas Medical Center; 2013. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/409.

Council of Science Editors:

Massarelli E. CXCR2 EXPRESSION IN TUMOR CELLS IS A POOR PROGNOSTIC FACTOR AND PROMOTES INVASION AND METASTASIS IN LUNG ADENOCARCINOMA. [Masters Thesis]. Texas Medical Center; 2013. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/409


Texas Medical Center

20. Cheung, Joey P. Image-Guided Proton Therapy for Online Dose-Evaluation and Adaptive Planning.

Degree: PhD, 2014, Texas Medical Center

  The main advantage for using protons in radiotherapy is their finite range in patients, allowing for potential improved sparing of normal tissues. However, this… (more)

Subjects/Keywords: adaptive radiation therapy; proton therapy; dose-guided radiation therapy; lung cancer; image-guided radiation therapy; dose calculation; spot scanning proton therapy; anatomical changes in radiation therapy; Medicine and Health Sciences; Oncology; Other Medicine and Health Sciences; Other Physics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cheung, J. P. (2014). Image-Guided Proton Therapy for Online Dose-Evaluation and Adaptive Planning. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/439

Chicago Manual of Style (16th Edition):

Cheung, Joey P. “Image-Guided Proton Therapy for Online Dose-Evaluation and Adaptive Planning.” 2014. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/439.

MLA Handbook (7th Edition):

Cheung, Joey P. “Image-Guided Proton Therapy for Online Dose-Evaluation and Adaptive Planning.” 2014. Web. 17 Jul 2018.

Vancouver:

Cheung JP. Image-Guided Proton Therapy for Online Dose-Evaluation and Adaptive Planning. [Internet] [Doctoral dissertation]. Texas Medical Center; 2014. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/439.

Council of Science Editors:

Cheung JP. Image-Guided Proton Therapy for Online Dose-Evaluation and Adaptive Planning. [Doctoral Dissertation]. Texas Medical Center; 2014. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/439


Texas Medical Center

21. Eley, John Gordon. Scanned Ion Beam Therapy for Thoracic Tumors.

Degree: PhD, 2013, Texas Medical Center

  Although frequently cured of Hodgkin lymphoma, adolescents and young adults can develop radiation induced second cancers. These patients could potentially benefit from scanned ion… (more)

Subjects/Keywords: ion therapy; carbon; proton therapy; motion; lung; Hodgkin lymphoma; 4D optimization; beam tracking; robustness; second cancer; Hemic and Lymphatic Diseases; Medical Biophysics; Medicine and Health Sciences; Oncology; Physical Sciences and Mathematics; Physics; Radiology; Respiratory Tract Diseases; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Eley, J. G. (2013). Scanned Ion Beam Therapy for Thoracic Tumors. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/400

Chicago Manual of Style (16th Edition):

Eley, John Gordon. “Scanned Ion Beam Therapy for Thoracic Tumors.” 2013. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/400.

MLA Handbook (7th Edition):

Eley, John Gordon. “Scanned Ion Beam Therapy for Thoracic Tumors.” 2013. Web. 17 Jul 2018.

Vancouver:

Eley JG. Scanned Ion Beam Therapy for Thoracic Tumors. [Internet] [Doctoral dissertation]. Texas Medical Center; 2013. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/400.

Council of Science Editors:

Eley JG. Scanned Ion Beam Therapy for Thoracic Tumors. [Doctoral Dissertation]. Texas Medical Center; 2013. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/400

22. Matney, Jason E. Investigation of Respiratory Motion Management Techniques for Proton and Photon Radiotherapy of Lung Cancer.

Degree: PhD, 2013, Texas Medical Center

  Protons as a source of therapeutic radiation can provide a substantial improvement over dose distributions that can be achieved with conventional sources of radiation… (more)

Subjects/Keywords: proton radiotherapy; lung cancer; respiratory motion; respiratory gating; 4D dose; IMRT; motion management; Medical Biophysics; Medicine and Health Sciences

…1 1.2 Radiation Therapy in Lung Cancer… …components for 152 stage III lung cancer patients. This figure is reprinted from reference 74 with… …gating, allowed for larger reduction of all lung and intermediate esophagus dose-volume indices… …1 1.1 Radiation Therapy for Cancer Treatment… …226 x LIST OF FIGURES Figure 1-1: Estimates from the American Cancer Society of the… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Matney, J. E. (2013). Investigation of Respiratory Motion Management Techniques for Proton and Photon Radiotherapy of Lung Cancer. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/404

Chicago Manual of Style (16th Edition):

Matney, Jason E. “Investigation of Respiratory Motion Management Techniques for Proton and Photon Radiotherapy of Lung Cancer.” 2013. Doctoral Dissertation, Texas Medical Center. Accessed July 17, 2018. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/404.

MLA Handbook (7th Edition):

Matney, Jason E. “Investigation of Respiratory Motion Management Techniques for Proton and Photon Radiotherapy of Lung Cancer.” 2013. Web. 17 Jul 2018.

Vancouver:

Matney JE. Investigation of Respiratory Motion Management Techniques for Proton and Photon Radiotherapy of Lung Cancer. [Internet] [Doctoral dissertation]. Texas Medical Center; 2013. [cited 2018 Jul 17]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/404.

Council of Science Editors:

Matney JE. Investigation of Respiratory Motion Management Techniques for Proton and Photon Radiotherapy of Lung Cancer. [Doctoral Dissertation]. Texas Medical Center; 2013. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/404

.